BCPP Review

Question 1

GAD diagnostic criteria

Answer 1

At least 3 symptoms (psychological/cognitive, physical, impairment/poor coping skills) for 6 months

Question 2

Generalized Anxiety Disorder Assessment (GAD-7)

Answer 2

Use: GAD
Self-rated
Screen/assess severity
5-10 mild, 10-15 moderate, 15-21 severe

Question 3

Hamilton Anxiety Scale (HAM-A)

Answer 3

Use: GAD
Clinician-rated
Assess severity/monitor response
0-17 mild, 18-24 severe, 25-30 severe

Question 4

Beck Anxiety Inventory (BAI)

Answer 4

Use: GAD
Self-rated
Screen/assess severe, distinguish from depression, more specific for panic symptoms
8-15 mild, 16-25 moderate, 26-63 severe

Question 5

Penn State Worry Questionnaire (PSWQ)

Answer 5

Use: GAD
Self-rated
Screen, evaluation of pathologic worry
<40 minimal anxiety, 40-60 moderate, >60 severe

Question 6

Zung Self-Rated Anxiety Scale (SAS)

Answer 6

Use: GAD
Self-rated
Screen, assess severity
45-59 moderate, 60-74 moderate to severe, 75-80 extreme

Question 7

GAD in pregnancy

Answer 7

SSRIs have most data
Avoid BZDs
Buspirone = category B
Hydroxyzine has no data

Question 8

GAD in peds

Answer 8

SSRIs first line
May required twice daily dosing for meds with shorter half life
Tx for 1 year minimum

Question 9

GAD in elderly

Answer 9

Avoid BZDs and hydroxyzine

Sertraline and citalopram effective, escitalopram not

Question 10

Landmark trial for GAD: SGA augmentation with quetiapine

Answer 10

Quetiapine effective as monotherapy, increased risk of d/c due to ADEs

Question 11

PD diagnostic criteria

Answer 11

Recurrent panic attacks (psychological and physical sx) plus at least 1 month of worry about the attacks

Question 12

Panic Disorder Severity Scale (PDSS)

Answer 12

Use: PD
Clinician-rated
Assess severity; if agoraphobia present, subtract two points for score interpretation 
0-1 normal 
2-5 borderline
6-9 slightly ill
10-13 moderately ill
14-28 markedly ill

Question 13

Pain and Agoraphobia Scale (PAS)

Answer 13

Use: PD
Two versions: observer and self rated
Diagnose, monitor treatment efficacy
Rated on a 0-4 Likert scale
Total score: add all items together, indicates severity of illness (mean~23)

Question 14

Sheehan Patient-Rated Anxiety Scale (SPRAS)

Answer 14

Use: PD
Self-rated
Assess severity
Rate 35 items on 5-point spectrum
Weighted towards somatic sx

Question 15

The Primary Care Evaluation of Mental Disorders Anxiety-Module (PRIME-MD)

Answer 15

Use: PD
Clinician rated
Screen in primary care setting
Four “yes” or “no” questions

Question 16

PTSD Diagnostic Criteria

Answer 16

exposure to event, intrusive sx, avoidance sx, negative mood, hyperarousal ≥1 month

Question 17

Clinician Administered PTSD Scale (CAPS)

Answer 17

Use: PTSD
Clinician-rated
Gold standard to diagnose and assess severity
Diagnosis = 1 “B” + 3 “C” + 2 “D” sx
Calculate frequency/intensity scores to assess severity

Question 18

PTSD Checklist (civilian/military versions available)

Answer 18

Use: PTSD
Self-rated
Diagnose, screen, monitor treatment efficacy
Cut off scores: 47 for civilian, 50 for military (out of 85 total)

Question 19

Impact of Event Scale-Revised (IES-R)

Answer 19

Use: PTSD
Self-rated
Assess distress caused by event, monitor treatment efficacy
Total score: 0-88
Subscale scores for intrusion, avoidance, hyperarousal

Question 20

PTSD Symptom Scale-Interview Version (PSS-I)

Answer 20

Use: PTSD
Administered by trained lay interviewer
Diagnose, assess severity
Ratings assigned to reflect frequency and severity

Question 21

Mississippi Scale for Combat-Related PTSD (M-PTSD)

Answer 21

Use: PTSD
Self-rated
Diagnose, screen
Rated on 5-point Likert scale, reflect PTSD symptom severity